Allison Hager
Dermatology · Millsboro, DENPI 1346738853
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in DE, where the typical reported total is $5,548.
Across 130 payments — averaging $29.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$849
- Lilly USA, LLC$728
- AstraZeneca$414
- Johnson & Johnson$384
- AbbVie$312
- Takeda Pharmaceuticals U.S.A., Inc.$187
- plus $911 from 14 others
What the payments were for
- Food & beverage$3,60995%
- Education$1775%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 15 | $849 |
| Lilly USA, LLC | 28 | $728 |
| AstraZeneca | 8 | $414 |
| Johnson & Johnson | 14 | $384 |
| AbbVie | 22 | $312 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $187 |
| Ardelyx, Inc. | 6 | $125 |
| Novartis | 7 | $125 |
| Idorsia Pharmaceuticals US Inc | 2 | $123 |
| Amgen | 1 | $122 |
| UCB, Inc. | 4 | $102 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| Tactile Systems Technology Inc | 1 | $59 |
| Novo Nordisk | 3 | $54 |
| Sanofi | 1 | $37 |
| Exact Sciences | 1 | $35 |
| Bayer | 1 | $20 |
| Phadia US Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,786 in reported general payments places this provider in the 40th percentile of 23 dermatology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 36 | $339,418 |
| Metronidazole | 79 | $5,158 |
| Clobetasol Propionate | 63 | $2,568 |
| Ketoconazole | 104 | $1,892 |
| Azelaic Acid | 13 | $1,797 |
| Triamcinolone Acetonide | 176 | $1,484 |
| Clindamycin Phosphate | 32 | $871 |
| ValacyclovirValacyclovir Hcl | 19 | $737 |
| Fluocinonide | 12 | $549 |
| Montelukast Sodium | 25 | $545 |
| NyamycNystatin | 22 | $428 |
| Ciclopirox | 13 | $349 |
| Nystatin | 17 | $339 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Millsboro
- Guy WebsterHockessin$52K
- Kiera BoothNewark$50K
- Thomas BurkeNewark$21K
- Michael RosenthalWilmington$20K
- Gina CaputoNewark$13K
- Lori SpencerNewark$13K
- Sara MoghaddamSelbyville$12K
- Curtis AsburySelbyville$11K
- Helen MashekNewark$9K
- Katrina HansenHockessin$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.